24th Consecutive Profitable Quarter Earns $.08 Per Diluted Share
LARGO, Fla., Feb. 26 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the second quarter ended December 31, 2008 (FY2009).
Net sales, excluding royalty income, increased 1.2% to $1,530,242 in FY2009 second quarter, compared with $1,512,361 in the previous year second quarter (FY2008). The increase was primarily a result of continued growth of the Company's C-Vue brand disposable specialty contact lenses, sold exclusively to licensed eye care professionals.
FY2009 second quarter net income was $358,945, compared with $375,915 in the previous year second quarter. Excluding a one-time favorable tax adjustment of $44,422 in the previous year second quarter, FY2009 second quarter net income increased 8.3%.
Royalty income for the FY2009 second quarter increased 3.0% to a record second quarter of $666,569 compared with $646,849 in the prior-year quarter. Sales of licensed products by our licensee Bausch & Lomb continue to increase, resulting in continued royalty income growth.
FY2009 second quarter income before taxes increased 11.9% to a record second quarter of $606,717 compared with $542,257 in the prior-year quarter. After recording net income tax expense of $247,772, Unilens reported net income of $358,945 for the quarter, or $0.08 per diluted share. In the FY2008 second quarter, the Company reported net income of $375,915, or $0.08 per diluted share, which included income tax expense of $166,342.
"We are very pleased with our second quarter results, considering the current economic environment," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc. "Double-digit growth from our C-Vue brand of lenses sold exclusively to independent practitioners, combined with a 3% growth in royalty revenue derived from Bausch & Lomb's sales of multifocal lenses that use our key technologies, was responsible for our record performance."
"I am also pleased to report that the Unilens Board of Directors declared its regular quarterly dividend of US $0.09 per common share, payable this Friday, February 27, 2009. "This decision was based on the Company's strong balance sheet, and projected operating cash flows and is consistent with the Board's commitment that shareholders should share directly in the earnings achieved by management while continuing to execute our growth strategy," concluded Mr. Pecora.
For the six months ended December 31, 2008, net sales excluding royalty income, increased 3.3% to $3,291,768, as compared to $3,185,722 for the prior-year six months. Net sales of the Company's C-Vue brand disposable contact lenses increased approximately 11.3% during the first half of fiscal year 2009, while sales of replacement products lines declined, as expected.
Net Income for the six months increased 9.6% to $825,312, or $0.18 per diluted share, compared with $753,211, or $0.17 per diluted share in the prior-year 6 months.
Royalty income for the six months ended December 31, 2008 increased 9.6% to a record $1,379,966, compared with $1,259,648 in the prior-year 6 months, demonstrating continued demand for sales of licensed products by our licensee Bausch & Lomb.
Income before taxes for the six months ended December 31, 2008 increased 18.7% to $1,374,976, compared with $1,158,758 in the prior-year 6 months. After recording net income tax expense of $549,664, Unilens reported net income of $825,312, or $0.18 per diluted share, for the six months ended December 31, 2008. This compared with net income of $753,211, or $0.17 per diluted share, in the prior-year 6 months of fiscal year 2008, which included net income tax expense of $405,547.
About Unilens Vision Inc. - "The Independent Eye Care Professionals Contact Lens Company"
Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVICF" as well as the Canadian TSX Venture Exchange under the symbol "UVI".
(Note: All financial information in this release is stated in U.S. Dollars.)
The information contained in this news release, other than historical information, consists of forward-looking statements that involve risk and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For more information, please contact:
Leonard F. Barker, CFO, Unilens Vision Inc. at (727) 544-2531
UNILENS VISION INC. SECOND QUARTER - FISCAL 2009 CONDENSED CONSOLIDATED FINANCIAL INFORMATION (All figures in U.S. Dollars) RESULTS OF OPERATIONS Three Months Three Months Six Months Six Months Ended Ended Ended Ended December 31, December 31, December 31, December 31, 2008 2007 2008 2007 Sales $1,530,242 $1,512,361 $ 3,291,768 $3,185,722 Cost of sales 873,498 885,453 1,808,630 1,789,850 656,744 626,908 1,483,138 1,395,872 Expenses 703,341 715,190 1,475,302 1,470,142 (Loss) income from operations (46,597) (88,282) 7,836 (74,270) Other items: Royalty income 666,569 646,849 1,379,966 1,259,648 Other expense (9,074) (21,775) (6,489) (48,916) Remeasurement (expense) income (4,557) 471 (8,984) 3,012 Interest income 376 4,994 2,647 19,284 653,314 630,539 1,367,140 1,233,028 Income before income tax expense 606,717 542,257 1,374,976 1,158,758 Income tax expense 247,772 166,342 549,664 405,547 Net income for the period $358,945 $375,915 $825,312 $753,211 Net income per common share: Basic $0.08 $0.08 $0.18 $0.17 Diluted $0.08 $0.08 $0.18 $0.17 CASH FLOWS Provided (used) by: Operating activities $588,372 $265,988 $1,295,055 $955,246 Investing activities (32,461) (1,636) (65,061) (29,759) Financing activities (409,564) (409,564) (2,184,343) (2,153,572) Decrease in cash $146,347 $(145,212) $(954,349) $(1,228,085) BALANCE SHEET June 30, December 31, December 31, 2008 2008 2007 Cash $1,603,476 $640,143 $736,639 Total assets 6,784,128 5,272,295 6,331,743 Current liabilities 957,434 804,632 563,301 Total liabilities 957,434 804,632 563,301 Stockholders' equity $5,826,694 $4,467,663 $5,768,442
|SOURCE Unilens Vision Inc.|
Copyright©2009 PR Newswire.
All rights reserved